Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Many people who received any of the authorized COVID-19 vaccines are now eligible for an additional dose of their choice.
People who received a shortened course of antiviral therapy were less likely to be cured.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
The health and prevention benefits of an undetectable viral load may be uniquely important in the American health care system.
Compared to other common HIV treatments, dolutegravir-based regimens maintained viral suppression even without perfect adherence.
However, no association was found between drinking coffee and liver fat accumulation.
Some types of lymphoma are considered AIDS-defining illnesses, but that doesn’t mean they’re caused by HIV itself.
Co-occurring health disorders appear to contribute to increased risk, NIH study suggests.
People who received the Moderna COVID-19 vaccine had strong immune memory of SARS-CoV-2 six months after vaccination.
Timely testing and treatment could improve outcomes for young people who inject drugs.
Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.
Long-awaited results from the ANCHOR study suggest screening to detect precancerous lesions should be part of routine care.
A majority people with oral and throat cancer tested positive for DNA from high-risk HPV types in their saliva.
Gay and bi men who used drugs during sex were also more likely to miss doses of their HIV meds.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.